How has Mineralys Therapeutics, Inc.'s stock issuance proceeds changed year-over-year?

Mineralys Therapeutics, Inc.'s stock issuance proceeds decreased by 97.9% year-over-year, from $189.17M to $4.06M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Mineralys Therapeutics, Inc. MLYS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Aurinia PharmaceuticalsAUPH

$713K-92.3%

Crinetics PharmaceuticalsCRNX

$380.51M—

Stoke Therapeutics, Inc.STOK

$3.21M+219%

ArriVent BioPharma, Inc.AVBP

$54.72M+740%

Kiniksa Pharmaceuticals International, plcKNSA

$6.39M+101%

CytokineticsCYTK

$11.35M—

Other financials

Income statement

See full

Operating income-$45.3M-2.0%

Net income-$39.3M+6.8%

EPS (diluted)-$0.47+40.5%

Balance sheet

See full

Cash & equivalents$1.2M-14.6%

Total equity$638.1M+86.8%

Total assets$652.9M+83.9%

Cash flow

See full

Operating cash flow-$39.5M+13.2%

CapEx$15.0K—

Free cash flow-$37.9M+43.3%

Valuation

See full

Market cap$2.26B+124%

Returns & leverage

See full

Return on equity-31%-9.6pp

Current ratio44.3×+17.8×

Where this comes from

Reported directly by Mineralys Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mineralys Therapeutics, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mineralys Therapeutics, Inc.'s stock issuance proceeds?: Mineralys Therapeutics, Inc. (MLYS) reported stock issuance proceeds of $4.06M in Q1 2026.
How has Mineralys Therapeutics, Inc.'s stock issuance proceeds changed year-over-year?: Mineralys Therapeutics, Inc.'s stock issuance proceeds decreased by 97.9% year-over-year, from $189.17M to $4.06M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.